Loading…
Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases
Objectives. To compare phytoestrogen tissue levels in men with small-volume benign prostatic hyperplasia (BPH), large-volume BPH, and prostate cancer (PCa). Prostatic tissue samples of men consuming a Western diet who underwent surgery for BPH (n = 63) or PCa (n = 31) were collected and frozen at −4...
Saved in:
Published in: | Urology (Ridgewood, N.J.) N.J.), 2004-10, Vol.64 (4), p.707-711 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c391t-c1d82ae150e2c03d27d52896957047c97e23bdcbe83733792c248fe7cfce92413 |
---|---|
cites | cdi_FETCH-LOGICAL-c391t-c1d82ae150e2c03d27d52896957047c97e23bdcbe83733792c248fe7cfce92413 |
container_end_page | 711 |
container_issue | 4 |
container_start_page | 707 |
container_title | Urology (Ridgewood, N.J.) |
container_volume | 64 |
creator | BrÖssner, Clemens Petritsch, Karin Fink, Klaus Auprich, Marco Madersbacher, Stephan Adlercreutz, Herman Rehak, Peter Petritsch, Peter |
description | Objectives. To compare phytoestrogen tissue levels in men with small-volume benign prostatic hyperplasia (BPH), large-volume BPH, and prostate cancer (PCa).
Prostatic tissue samples of men consuming a Western diet who underwent surgery for BPH (n = 63) or PCa (n = 31) were collected and frozen at −40°C. In the tissue samples, the enterolactone and genistein levels were determined in duplicate by monoclonal antibody-based immunoassays. We subsequently compared the tissue levels in patients with BPH and PCa and studied the impact of enterolactone and genistein on prostate volume.
The enterolactone tissue levels were comparable in patients with BPH and PCa and revealed no correlation to prostate volume. The genistein tissue levels tended to be lower in patients with PCa (median 8.4 ng/g dry weight) compared with the entire BPH group (11.0 ng/g dry weight;
P = 0.072). In addition, the genistein tissue levels were significantly greater in men with small-volume BPH (median 20.9 ng/g dry weight) compared with those with large-volume BPH (8.8 ng/g dry weight;
P = 0.023).
Our data suggest an involvement of genistein in the pathogenesis of BPH and, possibly, of PCa. The impact of enterolactone is currently unknown. |
doi_str_mv | 10.1016/j.urology.2004.04.046 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66987162</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090429504005394</els_id><sourcerecordid>66987162</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-c1d82ae150e2c03d27d52896957047c97e23bdcbe83733792c248fe7cfce92413</originalsourceid><addsrcrecordid>eNqFkEFvFCEUx4nR2G31I2i46G1WYGZgOBnTaDVpoof2TFh4s8tmdlh5TM0e_O5ld8fUW5OXQOD3Hn9-hLzjbMkZl5-2yynFIa4PS8FYszyVfEEWvBWq0lq3L8mCMc2qRuj2glwibhljUkr1mlzwttFcMbkgf39tDjkC5hTXMNIcECegAzzAgDSMdAVjWI90nyJmm4Ojm8Me0n6wGCy1o_93A9TZ0UE6neUNhLJDjC6UpjjSPyFv_hviA4JFwDfkVW8HhLfzekXuv329u_5e3f68-XH95bZytea5ctx3wgJvGQjHai-Ub0WnpW4Va5TTCkS98m4FXa3qWmnhRNP1oFzvQIuG11fk43luifB7Kr81u4AOhsGOECc0UupOcSkK2J5BV7Jigt7sU9jZdDCcmaN3szWzd3P0bk4lS9_7-YFptQP_1DWLLsCHGbDo7NCnYivgEycF57U6Jv185op_eAiQDLoAxawPCVw2PoZnojwCBYWnWg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66987162</pqid></control><display><type>article</type><title>Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases</title><source>ScienceDirect Freedom Collection</source><creator>BrÖssner, Clemens ; Petritsch, Karin ; Fink, Klaus ; Auprich, Marco ; Madersbacher, Stephan ; Adlercreutz, Herman ; Rehak, Peter ; Petritsch, Peter</creator><creatorcontrib>BrÖssner, Clemens ; Petritsch, Karin ; Fink, Klaus ; Auprich, Marco ; Madersbacher, Stephan ; Adlercreutz, Herman ; Rehak, Peter ; Petritsch, Peter</creatorcontrib><description>Objectives. To compare phytoestrogen tissue levels in men with small-volume benign prostatic hyperplasia (BPH), large-volume BPH, and prostate cancer (PCa).
Prostatic tissue samples of men consuming a Western diet who underwent surgery for BPH (n = 63) or PCa (n = 31) were collected and frozen at −40°C. In the tissue samples, the enterolactone and genistein levels were determined in duplicate by monoclonal antibody-based immunoassays. We subsequently compared the tissue levels in patients with BPH and PCa and studied the impact of enterolactone and genistein on prostate volume.
The enterolactone tissue levels were comparable in patients with BPH and PCa and revealed no correlation to prostate volume. The genistein tissue levels tended to be lower in patients with PCa (median 8.4 ng/g dry weight) compared with the entire BPH group (11.0 ng/g dry weight;
P = 0.072). In addition, the genistein tissue levels were significantly greater in men with small-volume BPH (median 20.9 ng/g dry weight) compared with those with large-volume BPH (8.8 ng/g dry weight;
P = 0.023).
Our data suggest an involvement of genistein in the pathogenesis of BPH and, possibly, of PCa. The impact of enterolactone is currently unknown.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/j.urology.2004.04.046</identifier><identifier>PMID: 15491706</identifier><identifier>CODEN: URGYAZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>4-Butyrolactone - analogs & derivatives ; 4-Butyrolactone - analysis ; Adenocarcinoma - chemistry ; Adenocarcinoma - pathology ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Diet ; Genistein - analysis ; Gynecology. Andrology. Obstetrics ; Humans ; Lignans - analysis ; Male ; Male genital diseases ; Medical sciences ; Middle Aged ; Nephrology. Urinary tract diseases ; Organ Size ; Phytoestrogens - analysis ; Prostate - chemistry ; Prostate - pathology ; Prostatic Hyperplasia - metabolism ; Prostatic Hyperplasia - pathology ; Prostatic Neoplasms - chemistry ; Prostatic Neoplasms - pathology ; Tumors ; Tumors of the urinary system ; Urinary tract. Prostate gland</subject><ispartof>Urology (Ridgewood, N.J.), 2004-10, Vol.64 (4), p.707-711</ispartof><rights>2004 Elsevier Inc.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-c1d82ae150e2c03d27d52896957047c97e23bdcbe83733792c248fe7cfce92413</citedby><cites>FETCH-LOGICAL-c391t-c1d82ae150e2c03d27d52896957047c97e23bdcbe83733792c248fe7cfce92413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16211371$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15491706$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BrÖssner, Clemens</creatorcontrib><creatorcontrib>Petritsch, Karin</creatorcontrib><creatorcontrib>Fink, Klaus</creatorcontrib><creatorcontrib>Auprich, Marco</creatorcontrib><creatorcontrib>Madersbacher, Stephan</creatorcontrib><creatorcontrib>Adlercreutz, Herman</creatorcontrib><creatorcontrib>Rehak, Peter</creatorcontrib><creatorcontrib>Petritsch, Peter</creatorcontrib><title>Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>Objectives. To compare phytoestrogen tissue levels in men with small-volume benign prostatic hyperplasia (BPH), large-volume BPH, and prostate cancer (PCa).
Prostatic tissue samples of men consuming a Western diet who underwent surgery for BPH (n = 63) or PCa (n = 31) were collected and frozen at −40°C. In the tissue samples, the enterolactone and genistein levels were determined in duplicate by monoclonal antibody-based immunoassays. We subsequently compared the tissue levels in patients with BPH and PCa and studied the impact of enterolactone and genistein on prostate volume.
The enterolactone tissue levels were comparable in patients with BPH and PCa and revealed no correlation to prostate volume. The genistein tissue levels tended to be lower in patients with PCa (median 8.4 ng/g dry weight) compared with the entire BPH group (11.0 ng/g dry weight;
P = 0.072). In addition, the genistein tissue levels were significantly greater in men with small-volume BPH (median 20.9 ng/g dry weight) compared with those with large-volume BPH (8.8 ng/g dry weight;
P = 0.023).
Our data suggest an involvement of genistein in the pathogenesis of BPH and, possibly, of PCa. The impact of enterolactone is currently unknown.</description><subject>4-Butyrolactone - analogs & derivatives</subject><subject>4-Butyrolactone - analysis</subject><subject>Adenocarcinoma - chemistry</subject><subject>Adenocarcinoma - pathology</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Diet</subject><subject>Genistein - analysis</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Lignans - analysis</subject><subject>Male</subject><subject>Male genital diseases</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Organ Size</subject><subject>Phytoestrogens - analysis</subject><subject>Prostate - chemistry</subject><subject>Prostate - pathology</subject><subject>Prostatic Hyperplasia - metabolism</subject><subject>Prostatic Hyperplasia - pathology</subject><subject>Prostatic Neoplasms - chemistry</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Tumors</subject><subject>Tumors of the urinary system</subject><subject>Urinary tract. Prostate gland</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqFkEFvFCEUx4nR2G31I2i46G1WYGZgOBnTaDVpoof2TFh4s8tmdlh5TM0e_O5ld8fUW5OXQOD3Hn9-hLzjbMkZl5-2yynFIa4PS8FYszyVfEEWvBWq0lq3L8mCMc2qRuj2glwibhljUkr1mlzwttFcMbkgf39tDjkC5hTXMNIcECegAzzAgDSMdAVjWI90nyJmm4Ojm8Me0n6wGCy1o_93A9TZ0UE6neUNhLJDjC6UpjjSPyFv_hviA4JFwDfkVW8HhLfzekXuv329u_5e3f68-XH95bZytea5ctx3wgJvGQjHai-Ub0WnpW4Va5TTCkS98m4FXa3qWmnhRNP1oFzvQIuG11fk43luifB7Kr81u4AOhsGOECc0UupOcSkK2J5BV7Jigt7sU9jZdDCcmaN3szWzd3P0bk4lS9_7-YFptQP_1DWLLsCHGbDo7NCnYivgEycF57U6Jv185op_eAiQDLoAxawPCVw2PoZnojwCBYWnWg</recordid><startdate>20041001</startdate><enddate>20041001</enddate><creator>BrÖssner, Clemens</creator><creator>Petritsch, Karin</creator><creator>Fink, Klaus</creator><creator>Auprich, Marco</creator><creator>Madersbacher, Stephan</creator><creator>Adlercreutz, Herman</creator><creator>Rehak, Peter</creator><creator>Petritsch, Peter</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041001</creationdate><title>Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases</title><author>BrÖssner, Clemens ; Petritsch, Karin ; Fink, Klaus ; Auprich, Marco ; Madersbacher, Stephan ; Adlercreutz, Herman ; Rehak, Peter ; Petritsch, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-c1d82ae150e2c03d27d52896957047c97e23bdcbe83733792c248fe7cfce92413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>4-Butyrolactone - analogs & derivatives</topic><topic>4-Butyrolactone - analysis</topic><topic>Adenocarcinoma - chemistry</topic><topic>Adenocarcinoma - pathology</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Diet</topic><topic>Genistein - analysis</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Lignans - analysis</topic><topic>Male</topic><topic>Male genital diseases</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Organ Size</topic><topic>Phytoestrogens - analysis</topic><topic>Prostate - chemistry</topic><topic>Prostate - pathology</topic><topic>Prostatic Hyperplasia - metabolism</topic><topic>Prostatic Hyperplasia - pathology</topic><topic>Prostatic Neoplasms - chemistry</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Tumors</topic><topic>Tumors of the urinary system</topic><topic>Urinary tract. Prostate gland</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BrÖssner, Clemens</creatorcontrib><creatorcontrib>Petritsch, Karin</creatorcontrib><creatorcontrib>Fink, Klaus</creatorcontrib><creatorcontrib>Auprich, Marco</creatorcontrib><creatorcontrib>Madersbacher, Stephan</creatorcontrib><creatorcontrib>Adlercreutz, Herman</creatorcontrib><creatorcontrib>Rehak, Peter</creatorcontrib><creatorcontrib>Petritsch, Peter</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BrÖssner, Clemens</au><au>Petritsch, Karin</au><au>Fink, Klaus</au><au>Auprich, Marco</au><au>Madersbacher, Stephan</au><au>Adlercreutz, Herman</au><au>Rehak, Peter</au><au>Petritsch, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>2004-10-01</date><risdate>2004</risdate><volume>64</volume><issue>4</issue><spage>707</spage><epage>711</epage><pages>707-711</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><coden>URGYAZ</coden><abstract>Objectives. To compare phytoestrogen tissue levels in men with small-volume benign prostatic hyperplasia (BPH), large-volume BPH, and prostate cancer (PCa).
Prostatic tissue samples of men consuming a Western diet who underwent surgery for BPH (n = 63) or PCa (n = 31) were collected and frozen at −40°C. In the tissue samples, the enterolactone and genistein levels were determined in duplicate by monoclonal antibody-based immunoassays. We subsequently compared the tissue levels in patients with BPH and PCa and studied the impact of enterolactone and genistein on prostate volume.
The enterolactone tissue levels were comparable in patients with BPH and PCa and revealed no correlation to prostate volume. The genistein tissue levels tended to be lower in patients with PCa (median 8.4 ng/g dry weight) compared with the entire BPH group (11.0 ng/g dry weight;
P = 0.072). In addition, the genistein tissue levels were significantly greater in men with small-volume BPH (median 20.9 ng/g dry weight) compared with those with large-volume BPH (8.8 ng/g dry weight;
P = 0.023).
Our data suggest an involvement of genistein in the pathogenesis of BPH and, possibly, of PCa. The impact of enterolactone is currently unknown.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>15491706</pmid><doi>10.1016/j.urology.2004.04.046</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0090-4295 |
ispartof | Urology (Ridgewood, N.J.), 2004-10, Vol.64 (4), p.707-711 |
issn | 0090-4295 1527-9995 |
language | eng |
recordid | cdi_proquest_miscellaneous_66987162 |
source | ScienceDirect Freedom Collection |
subjects | 4-Butyrolactone - analogs & derivatives 4-Butyrolactone - analysis Adenocarcinoma - chemistry Adenocarcinoma - pathology Aged Aged, 80 and over Biological and medical sciences Diet Genistein - analysis Gynecology. Andrology. Obstetrics Humans Lignans - analysis Male Male genital diseases Medical sciences Middle Aged Nephrology. Urinary tract diseases Organ Size Phytoestrogens - analysis Prostate - chemistry Prostate - pathology Prostatic Hyperplasia - metabolism Prostatic Hyperplasia - pathology Prostatic Neoplasms - chemistry Prostatic Neoplasms - pathology Tumors Tumors of the urinary system Urinary tract. Prostate gland |
title | Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T14%3A24%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phytoestrogen%20tissue%20levels%20in%20benign%20prostatic%20hyperplasia%20and%20prostate%20cancer%20and%20their%20association%20with%20prostatic%20diseases&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Br%C3%96ssner,%20Clemens&rft.date=2004-10-01&rft.volume=64&rft.issue=4&rft.spage=707&rft.epage=711&rft.pages=707-711&rft.issn=0090-4295&rft.eissn=1527-9995&rft.coden=URGYAZ&rft_id=info:doi/10.1016/j.urology.2004.04.046&rft_dat=%3Cproquest_cross%3E66987162%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c391t-c1d82ae150e2c03d27d52896957047c97e23bdcbe83733792c248fe7cfce92413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=66987162&rft_id=info:pmid/15491706&rfr_iscdi=true |